
About Trident Lifeline Limited
Data last updated:
Trident Lifeline Limited is a public limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L51909GJ2014PLC078227. Its GSTIN is 24AAECT8906D1ZG (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 543616.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.96 Cr. It is led by directors including Shravan H Patel (Managing Director) and Rupaben Chetan Jariwala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹129.02 Cr, a growth of 48.4% compared to the previous year. For the same year it recorded a net profit of ₹19.03 Cr (net margin 14.7%) and EBITDA of ₹28.11 Cr (EBITDA margin 21.8%). The net worth stands at ₹100.4 Cr (up 55.8% YoY). Total assets are valued at ₹180.95 Cr (up 46.2% YoY).
The company has about 47 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Trident Lifeline. As per MCA filings, the company has open charges of ₹142.39 Cr and satisfied charges of ₹1.58 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 435 overdue payments to 43 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tridentlifeline.com.
Company details
CIN history
Trident Lifeline has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51909GJ2014PLC078227, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51909GJ2014PLC078227 | Current |
| U51909GJ2014PTC078227 | Previous |
| U51909GJ2014PLC078227 | Previous |
Contact details
Trident Lifeline Limited's registered office is in Surat, Gujarat. Its website is tridentlifeline.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trident Lifeline Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Trident Lifeline operates one associated brand: Trident Lifeline. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of liquid orals, topical preparations, capsule, and other drugs | tridentlifeline.com |
Business activity
The main business activity of Trident Lifeline is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Trident Lifeline Limited, buy the company report.
Financials of Trident Lifeline Limited
FY 2025-26 filings availableTrident Lifeline Limited reported revenue of ₹129.02 Cr (up 48.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 129 | 86.96 | 44.63 | 31.69 | 21.77 |
| Revenue growth | +48.4% | +94.9% | +40.8% | +45.6% | - |
| EBITDA | 28.11 | 15.00 | 8.23 | 6.26 | 2.71 |
| EBITDA margin | +21.8% | +17.3% | +18.4% | +19.8% | +12.5% |
| Profit before tax | 27.19 | 13.60 | 8.69 | 6.58 | 2.98 |
| Net profit | 19.03 | 11.73 | 6.33 | 6.02 | 3.94 |
| Net profit margin | +14.8% | +13.5% | +14.2% | +19.0% | +18.1% |
| EPS (₹) | 16.32 | 10.22 | 5.52 | 5.23 | 4.93 |
| Balance sheet | |||||
| Total assets | 181 | 124 | 72.43 | 54.87 | 7.30 |
| Net worth | 100 | 64.46 | 52.90 | 45.64 | 4.78 |
| Total debt | 72.99 | 54.03 | 18.41 | 7.69 | 2.46 |
| Cash & bank | 4.22 | 2.46 | 6.65 | 13.78 | 0.16 |
| Net working capital | 84.56 | 58.58 | 37.32 | 41.51 | 4.13 |
| Cash flow | |||||
| Cash from operations | 4.69 | (3.98) | 2.23 | (19.00) | (0.21) |
| Cash from investing | (36.61) | (13.71) | (20.36) | (9.69) | (0.45) |
| Cash from financing | 33.68 | 13.50 | 11.01 | 42.28 | 0.80 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.08 | 33.72 | 49.95 | 25.71 | 31.34 | 23.61 | 34.01 | 11.83 |
| Revenue growth (YoY) | +50.2% | +42.8% | +46.9% | +117.3% | +102.9% | +79.5% | - | - |
| Other income | 0.97 | 0.57 | 1.62 | 4.63 | 1.67 | 1.35 | 1.87 | 0.56 |
| EBITDA | 11.32 | 8.52 | 10.98 | 5.09 | 6.86 | 5.17 | 8.53 | 4.08 |
| EBITDA margin | +24.0% | +25.3% | +22.0% | +19.8% | +21.9% | +21.9% | +25.1% | +34.5% |
| Depreciation | 1.56 | 1.62 | 1.23 | 2.46 | 0.91 | 1.46 | 2.74 | 0.61 |
| Interest | 1.93 | 0.86 | 0.77 | 1.24 | 0.99 | 1.13 | 1.55 | 0.55 |
| Profit before tax | 8.80 | 6.61 | 10.60 | 6.02 | 6.63 | 3.93 | 6.11 | 3.48 |
| Tax | 2.21 | 1.54 | 3.82 | 1.37 | 1.54 | 1.15 | (0.02) | 0.92 |
| Net profit | 6.59 | 5.07 | 6.78 | 4.65 | 5.09 | 2.78 | 6.13 | 2.56 |
| EPS (₹) | 5.69 | 4.27 | 5.76 | 3.72 | 4.27 | 2.66 | 6.15 | 2.42 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 102 | 67.80 | 44.65 | 31.69 | 21.77 | 9.62 | 4.93 |
| Revenue growth | +50.3% | +51.9% | +40.9% | +45.6% | +126.3% | +95.1% | - |
| EBITDA | 24.33 | 17.66 | 8.87 | 6.26 | 2.71 | 1.26 | (0.28) |
| EBITDA margin | +23.9% | +26.1% | +19.9% | +19.8% | +12.5% | +13.1% | -5.7% |
| Profit before tax | 24.98 | 17.89 | 9.79 | 6.57 | 2.98 | 0.87 | (1.09) |
| Net profit | 18.09 | 13.04 | 7.03 | 6.01 | 3.94 | 0.65 | (0.82) |
| Net profit margin | +17.8% | +19.2% | +15.7% | +19.0% | +18.1% | +6.8% | -16.6% |
| EPS (₹) | 15.50 | 11.35 | 6.13 | 5.23 | 4.93 | 1.26 | (2.57) |
| Balance sheet | |||||||
| Total assets | 124 | 80.69 | 58.94 | 49.08 | 7.30 | 4.11 | 3.52 |
| Net worth | 99.09 | 65.73 | 52.68 | 45.63 | 4.78 | (0.47) | (3.00) |
| Total debt | 24.60 | 14.89 | 6.20 | 3.38 | 2.46 | 4.53 | 6.46 |
| Cash & bank | 4.07 | 2.11 | 6.01 | 13.77 | 0.13 | 0.09 | 0.12 |
| Net working capital | 75.54 | 52.49 | 38.69 | 40.44 | 4.11 | 0.40 | (0.05) |
| Cash flow | |||||||
| Cash from operations | 7.93 | 1.97 | 0.90 | (16.60) | (0.19) | 1.48 | (0.59) |
| Cash from investing | (20.07) | (7.88) | (11.01) | (5.56) | (0.50) | (0.56) | (0.08) |
| Cash from financing | 14.10 | 2.01 | 2.35 | 35.80 | 0.80 | (0.96) | 0.76 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.73 | 26.84 | 31.97 | 23.67 | 46.26 | 18.82 | 20.85 | 16.51 |
| Revenue growth (YoY) | -29.3% | +42.6% | +53.3% | +43.4% | +195.4% | +27.7% | - | - |
| Other income | 0.93 | 0.53 | 1.64 | 0.89 | 1.64 | 0.54 | 1.61 | 0.54 |
| Total expenses | 22.98 | 19.62 | 25.23 | 17.39 | 34.95 | 13.89 | 15.27 | 12.37 |
| EBITDA | 9.75 | 7.22 | 6.74 | 6.28 | 11.31 | 4.93 | 5.58 | 4.14 |
| EBITDA margin | +29.8% | +26.9% | +21.1% | +26.5% | +24.4% | +26.2% | +26.8% | +25.1% |
| Depreciation | 0.57 | 0.70 | 0.04 | 0.71 | 1.11 | 0.51 | 0.71 | 0.38 |
| Interest | 1.32 | 0.49 | 0.38 | 0.54 | 0.74 | 0.33 | 0.46 | 0.35 |
| Profit before tax | 8.79 | 6.56 | 7.96 | 5.92 | 11.10 | 4.63 | 6.02 | 3.95 |
| Tax | 2.21 | 1.54 | 2.29 | 1.91 | 2.69 | 1.15 | 1.66 | 0.92 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.08 | 33.72 | 49.95 | 25.71 | 31.34 | 23.61 | 34.01 | 11.83 |
| Revenue growth (YoY) | +50.2% | +42.8% | +46.9% | +117.3% | +102.9% | +79.5% | - | - |
| Other income | 0.97 | 0.57 | 1.62 | 4.63 | 1.67 | 1.35 | 1.87 | 0.56 |
| EBITDA | 11.32 | 8.52 | 10.98 | 5.09 | 6.86 | 5.17 | 8.53 | 4.08 |
| EBITDA margin | +24.0% | +25.3% | +22.0% | +19.8% | +21.9% | +21.9% | +25.1% | +34.5% |
| Depreciation | 1.56 | 1.62 | 1.23 | 2.46 | 0.91 | 1.46 | 2.74 | 0.61 |
| Interest | 1.93 | 0.86 | 0.77 | 1.24 | 0.99 | 1.13 | 1.55 | 0.55 |
| Profit before tax | 8.80 | 6.61 | 10.60 | 6.02 | 6.63 | 3.93 | 6.11 | 3.48 |
| Tax | 2.21 | 1.54 | 3.82 | 1.37 | 1.54 | 1.15 | (0.02) | 0.92 |
| Net profit | 6.59 | 5.07 | 6.78 | 4.65 | 5.09 | 2.78 | 6.13 | 2.56 |
| EPS (₹) | 5.69 | 4.27 | 5.76 | 3.72 | 4.27 | 2.66 | 6.15 | 2.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 129 | 86.96 | 44.63 | 31.69 | 21.77 |
| Revenue growth | +48.4% | +94.9% | +40.8% | +45.6% | - |
| Other income | 9.27 | 8.23 | 2.08 | 1.16 | 0.60 |
| Total expenses | 101 | 71.96 | 36.40 | 25.43 | 19.06 |
| Employee cost | 0.00 | 10.89 | 2.29 | 1.39 | 1.10 |
| EBITDA | 28.11 | 15.00 | 8.23 | 6.26 | 2.71 |
| EBITDA margin | +21.8% | +17.3% | +18.4% | +19.8% | +12.5% |
| Depreciation | 6.07 | 5.49 | 0.97 | 0.36 | 0.20 |
| Interest | 4.12 | 4.14 | 0.65 | 0.48 | 0.13 |
| Profit before tax | 27.19 | 13.60 | 8.69 | 6.58 | 2.98 |
| Tax | 7.88 | 3.12 | 2.75 | 0.56 | (0.96) |
| Net profit | 19.03 | 11.73 | 6.33 | 6.02 | 3.94 |
| Net profit margin | +14.8% | +13.5% | +14.2% | +19.0% | +18.1% |
| EPS (₹) | 16.32 | 10.22 | 5.52 | 5.23 | 4.93 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 11.93 | 11.50 | 11.50 | 11.50 | 8.00 |
| Reserves & surplus | 84.74 | 52.96 | 40.41 | 34.14 | (3.22) |
| Shareholders' funds (net worth) | 100 | 64.46 | 52.90 | 45.64 | 4.78 |
| Minority interest | 7.49 | 5.19 | 1.05 | 1.47 | 0.00 |
| Secured loans | 56.65 | 41.15 | 14.42 | 6.20 | 0.60 |
| Unsecured loans | 16.34 | 12.88 | 3.99 | 1.49 | 1.86 |
| Total debt | 72.99 | 54.03 | 18.41 | 7.69 | 2.46 |
| Total liabilities | 181 | 124 | 72.43 | 54.87 | 7.30 |
| Assets | |||||
| Gross block | 78.30 | 57.40 | 23.03 | 4.33 | 2.23 |
| Net block | 60.70 | 43.87 | 20.89 | 3.16 | 1.43 |
| Capital work in progress | 17.54 | 1.60 | 4.03 | 4.83 | 0.00 |
| Investments | 8.27 | 10.72 | 3.77 | 3.34 | 0.00 |
| Inventories | 36.44 | 28.24 | 12.58 | 7.17 | 3.71 |
| Sundry debtors | 73.65 | 27.68 | 13.44 | 12.09 | 4.97 |
| Cash & bank balances | 4.22 | 2.46 | 6.65 | 13.78 | 0.16 |
| Loans & advances | 25.18 | 31.99 | 19.29 | 16.17 | 1.83 |
| Total current assets | 139 | 90.37 | 51.96 | 49.21 | 10.67 |
| Total current liabilities | 54.93 | 31.79 | 14.64 | 7.70 | 6.54 |
| Net working capital | 84.56 | 58.58 | 37.32 | 41.51 | 4.13 |
| Total assets | 181 | 124 | 72.43 | 54.87 | 7.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 2.46 | 6.65 | 13.78 | 0.18 | 0.01 |
| Net cash from operating activities | 4.69 | (3.98) | 2.23 | (19.00) | (0.21) |
| Net cash from investing activities | (36.61) | (13.71) | (20.36) | (9.69) | (0.45) |
| Net cash from financing activities | 33.68 | 13.50 | 11.01 | 42.28 | 0.80 |
| Net change in cash | 1.76 | (4.19) | (7.13) | 13.60 | 0.14 |
| Closing cash | 4.22 | 2.46 | 6.65 | 13.78 | 0.16 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +48.4% | +94.9% | +40.8% | +45.6% | - |
| EBITDA growth | +87.4% | +82.3% | +31.5% | +131.0% | - |
| PBT growth | +100.1% | +56.5% | +32.1% | +120.8% | +9997.0% |
| Net income growth | +62.2% | +85.3% | +5.2% | +52.8% | - |
| Revenue CAGR (3Y) | +59.7% | +58.7% | - | - | - |
| EBITDA CAGR (3Y) | +65.1% | +76.9% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +15.0% | +12.1% | +13.3% | +19.0% | +18.1% |
| Return on capital employed | +22.3% | +18.7% | +15.0% | +22.1% | +29.7% |
| Return on net worth | +23.4% | +17.9% | +12.1% | +22.4% | +49.4% |
| Debt / equity | 0.77 | 0.62 | 0.26 | 0.20 | 0.51 |
| Long-term debt / equity | 0.43 | 0.38 | 0.17 | 0.10 | 0.30 |
| Interest cover | 24.09 | 43.53 | 8.95 | 8.14 | 5.18 |
| Efficiency & per share | |||||
| Fixed asset turnover | 1.90 | 2.16 | 3.26 | 9.66 | 9.76 |
| Inventory turnover | 3.99 | 4.26 | 4.52 | 5.83 | 5.87 |
| Debtors turnover | 2.55 | 4.23 | 3.50 | 3.72 | 4.38 |
| EPS (₹) | 15.96 | 10.22 | 5.52 | 5.23 | 4.93 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 81.02 | 56.05 | 45.14 | 39.69 | 5.97 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.73 | 26.84 | 31.97 | 23.67 | 46.26 | 18.82 | 20.85 | 16.51 |
| Revenue growth (YoY) | -29.3% | +42.6% | +53.3% | +43.4% | +195.4% | +27.7% | - | - |
| Other income | 0.93 | 0.53 | 1.64 | 0.89 | 1.64 | 0.54 | 1.61 | 0.54 |
| Total expenses | 22.98 | 19.62 | 25.23 | 17.39 | 34.95 | 13.89 | 15.27 | 12.37 |
| EBITDA | 9.75 | 7.22 | 6.74 | 6.28 | 11.31 | 4.93 | 5.58 | 4.14 |
| EBITDA margin | +29.8% | +26.9% | +21.1% | +26.5% | +24.4% | +26.2% | +26.8% | +25.1% |
| Depreciation | 0.57 | 0.70 | 0.04 | 0.71 | 1.11 | 0.51 | 0.71 | 0.38 |
| Interest | 1.32 | 0.49 | 0.38 | 0.54 | 0.74 | 0.33 | 0.46 | 0.35 |
| Profit before tax | 8.79 | 6.56 | 7.96 | 5.92 | 11.10 | 4.63 | 6.02 | 3.95 |
| Tax | 2.21 | 1.54 | 2.29 | 1.91 | 2.69 | 1.15 | 1.66 | 0.92 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 102 | 67.80 | 44.65 | 31.69 | 21.77 | 9.62 | 4.93 |
| Revenue growth | +50.3% | +51.9% | +40.9% | +45.6% | +126.3% | +95.1% | - |
| Other income | 4.17 | 3.14 | 2.20 | 1.15 | 0.60 | 0.16 | 0.07 |
| Total expenses | 77.57 | 50.14 | 35.78 | 25.43 | 19.06 | 8.36 | 5.21 |
| Employee cost | 0.00 | 2.51 | 1.55 | 1.39 | 1.10 | 0.70 | 0.71 |
| EBITDA | 24.33 | 17.66 | 8.87 | 6.26 | 2.71 | 1.26 | (0.28) |
| EBITDA margin | +23.9% | +26.1% | +19.9% | +19.8% | +12.5% | +13.1% | -5.7% |
| Depreciation | 1.86 | 1.53 | 0.77 | 0.36 | 0.20 | 0.14 | 0.12 |
| Interest | 1.66 | 1.38 | 0.51 | 0.48 | 0.13 | 0.41 | 0.76 |
| Profit before tax | 24.98 | 17.89 | 9.79 | 6.57 | 2.98 | 0.87 | (1.09) |
| Tax | 6.89 | 4.85 | 2.75 | 0.56 | (0.96) | 0.22 | (0.28) |
| Net profit | 18.09 | 13.04 | 7.03 | 6.01 | 3.94 | 0.65 | (0.82) |
| Net profit margin | +17.8% | +19.2% | +15.7% | +19.0% | +18.1% | +6.8% | -16.6% |
| EPS (₹) | 15.50 | 11.35 | 6.13 | 5.23 | 4.93 | 1.26 | (2.57) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.93 | 11.50 | 11.50 | 11.50 | 8.00 | 5.00 | 3.10 |
| Reserves & surplus | 83.43 | 54.23 | 41.18 | 34.13 | (3.22) | (5.47) | (6.10) |
| Shareholders' funds (net worth) | 99.09 | 65.73 | 52.68 | 45.63 | 4.78 | (0.47) | (3.00) |
| Secured loans | 21.20 | 13.02 | 6.20 | 2.73 | 0.60 | 0.00 | 0.00 |
| Unsecured loans | 3.40 | 1.87 | 0.00 | 0.65 | 1.86 | 4.53 | 6.46 |
| Total debt | 24.60 | 14.89 | 6.20 | 3.38 | 2.46 | 4.53 | 6.46 |
| Total liabilities | 124 | 80.69 | 58.94 | 49.08 | 7.30 | 4.11 | 3.52 |
| Assets | |||||||
| Gross block | 33.91 | 18.26 | 9.55 | 4.27 | 2.23 | 1.77 | 1.22 |
| Net block | 28.59 | 14.80 | 7.62 | 3.11 | 1.43 | 1.18 | 0.77 |
| Capital work in progress | 0.00 | 0.54 | 4.03 | 0.23 | 0.00 | 0.00 | 0.00 |
| Investments | 19.74 | 12.49 | 4.40 | 4.04 | 0.05 | 0.00 | 0.00 |
| Inventories | 23.22 | 16.57 | 11.06 | 7.17 | 3.71 | 5.27 | 0.94 |
| Sundry debtors | 49.34 | 20.40 | 13.76 | 12.15 | 4.97 | 0.64 | 1.31 |
| Cash & bank balances | 4.07 | 2.11 | 6.01 | 13.77 | 0.13 | 0.09 | 0.12 |
| Loans & advances | 33.41 | 30.05 | 22.15 | 14.77 | 1.83 | 1.74 | 0.45 |
| Total current assets | 110 | 69.13 | 52.98 | 47.86 | 10.64 | 7.74 | 2.82 |
| Total current liabilities | 34.50 | 16.64 | 14.29 | 7.42 | 6.53 | 7.34 | 2.87 |
| Net working capital | 75.54 | 52.49 | 38.69 | 40.44 | 4.11 | 0.40 | (0.05) |
| Total assets | 124 | 80.69 | 58.94 | 49.08 | 7.30 | 4.11 | 3.52 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.11 | 6.01 | 13.77 | 0.13 | 0.01 | 0.12 | 0.04 |
| Net cash from operating activities | 7.93 | 1.97 | 0.90 | (16.60) | (0.19) | 1.48 | (0.59) |
| Net cash from investing activities | (20.07) | (7.88) | (11.01) | (5.56) | (0.50) | (0.56) | (0.08) |
| Net cash from financing activities | 14.10 | 2.01 | 2.35 | 35.80 | 0.80 | (0.96) | 0.76 |
| Net change in cash | 1.96 | (3.90) | (7.76) | 13.64 | 0.11 | (0.03) | 0.08 |
| Closing cash | 4.07 | 2.11 | 6.01 | 13.77 | 0.13 | 0.09 | 0.12 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +50.3% | +51.9% | +40.9% | +45.6% | +126.3% | +95.1% | - |
| EBITDA growth | +37.8% | +99.1% | +41.7% | +131.0% | +115.1% | +550.0% | - |
| PBT growth | +39.6% | +82.7% | +49.0% | +120.5% | +242.5% | +9998.0% | +9997.0% |
| Net income growth | +38.7% | +85.5% | +17.0% | +52.5% | +506.2% | +179.3% | - |
| Revenue CAGR (3Y) | +47.6% | +46.0% | +66.8% | +85.9% | - | - | - |
| EBITDA CAGR (3Y) | +57.3% | +86.8% | +91.7% | - | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +17.8% | +19.2% | +15.8% | +19.0% | +18.1% | +6.8% | -16.4% |
| Return on capital employed | +26.1% | +27.6% | +19.1% | +23.7% | +31.0% | +19.2% | 0.0% |
| Return on net worth | +22.0% | +22.0% | +14.3% | +22.4% | +60.8% | +63.0% | 0.0% |
| Debt / equity | 0.24 | 0.18 | 0.10 | 0.12 | 1.62 | 0.00 | 0.00 |
| Long-term debt / equity | 0.08 | 0.08 | 0.04 | 0.04 | 1.36 | 0.00 | 0.00 |
| Interest cover | 7.47 | 8.56 | 6.30 | 8.14 | 5.18 | 36.61 | -190.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.91 | 4.88 | 6.46 | 9.75 | 10.89 | 6.43 | 4.04 |
| Inventory turnover | 5.12 | 4.91 | 4.90 | 5.83 | 4.85 | 3.10 | 5.24 |
| Debtors turnover | 2.92 | 3.97 | 3.45 | 3.70 | 7.76 | 9.87 | 3.76 |
| EPS (₹) | 15.16 | 11.35 | 6.13 | 5.23 | 4.93 | 1.26 | (2.57) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 79.91 | 57.16 | 45.81 | 39.68 | 5.97 | (0.94) | (9.69) |
To see the full year-wise statements and ratios of Trident Lifeline Limited, buy the company report.
Board of directors of Trident Lifeline Limited
Trident Lifeline has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardik Jigishkumar Desai | Director | 27 Jun 2022 | 4 Years 4 Months | Current |
| Shravan H Patel | Managing Director | 04 Jul 2022 | 4 Years 4 Months | Current |
| Ashish Anandsingh Bafna Also directs: TLL Ventures Private Limited | Director | 01 Sep 2025 | 1 Years 2 Months | Current |
| Rupaben Chetan Jariwala Also directs: VN Capital Services LLP, TLL Elements Private Limited | Whole-Time Director | 16 May 2024 | 2 Years 6 Months | Current |
| Falguni Bhavesh Jariwala | Director | 27 Apr 2024 | 2 Years 6 Months | Current |
| Mishal Shailesh Patel Also directs: Trident Texofab Limited | Director | 22 Jul 2023 | 3 Years 4 Months | Current |
Auditor
Trident Lifeline Limited is audited by A Bafna & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A Bafna & Associates | FY 2023 | 121901W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 62.60%, foreign institutional investors hold 5.20%, domestic institutional investors hold 0.30% and retail and other public shareholders hold 31.90%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 62.60% | 62.80% | 64.10% | 63.10% |
| Public | 37.40% | 37.20% | 35.90% | 36.90% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Aug 2026 | 101389751 | Axis Bank Limited | ₹2.29 Cr | Open | |
| 14 Jul 2026 | 101389789 | Axis Bank Limited | ₹2.29 Cr | Open | |
| 25 Jun 2026 | 101323896 | Others | ₹15 Cr | Open | |
| 12 Jun 2026 | 101323897 | Others | ₹15 Cr | Open | |
| 03 Nov 2025 | 101182491 | Others | ₹39.98 Lakh | Open |
To see the full charge records of Trident Lifeline Limited, buy the company report.
Total charge records: 19 View all charges
Deals & funding
Trident Lifeline Limited has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022.
Deals on record (5 of 19)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | IPO | ₹35.34 Cr | Investors: IPO - Trident Lifeline Limited, NAV Capital VCC- NAV Capital Emerging Star Fund, Bijal Mukesh Shah Huf, an individual |
| Dec 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Trident Texofab Limited |
| Dec 2016 | Rights issue | ₹1.2 Cr | Investors: Trident Texofab Limited , 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Trident Texofab Limited , 2 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Trident Texofab Limited Seller: an individual |
To see the full deal history of Trident Lifeline Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Trident Lifeline Limited has 2 court cases on record: 2 filed by Trident Lifeline. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0816-Letter Petition & Pil Matters : SLPs filed against judgments / orders passed by the High Courts in Writ Petitions filed as PIL) | Filed by the company against Hotel Shilpi India Private Ltd. Director, Manish Mahendrabhai Katagramwala, Residing at Bhaktibaug, Dholi Kui, Varachha Road, Surat Gujarat. ,Surat , Gujarat and 7 others | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against State of Gujarat and 2 others | Pending |
To see the full case history of Trident Lifeline Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Trident Lifeline Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 435 overdue payments to 43 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 43)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Shreeji Sharan Pharmapack LLP | |||
| an individual supplier |
To see the full MSME payment records of Trident Lifeline Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Trident Lifeline has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| TNS Pharma Private Limited | U24290GJ2021PTC128263 |
To see the full group structure of Trident Lifeline Limited, buy the company report.
Employees & EPFO
Trident Lifeline Limited has a workforce of 47 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 47 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Trident Lifeline Limited, buy the company report.
GST
Trident Lifeline has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECT8906D1ZG | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trident Lifeline Limited, buy the company report.
Recent activity
Trident Lifeline Limited has 17 board changes on record since 2020: 12 appointments and 5 cessations. The latest: Sachin Bhandari was appointed as Director on 13 Jun 2026.
36 earlier events are in the company report.
News
Frequently asked questions
Trident Lifeline is an active public limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2014 (12+ years old) and is registered under CIN L51909GJ2014PLC078227. Listed on BSE: 543616.
Trident Lifeline reported revenue of ₹129.02 Cr for FY 2025-26 (up 48.4% YoY) based on consolidated financials.
Trident Lifeline has 8 current directors:
- Shravan H Patel - Managing Director
- Rupaben Chetan Jariwala - Whole-Time Director
- Hardik Jigishkumar Desai - Director
- Ashish Anandsingh Bafna - Director
- Falguni Bhavesh Jariwala - Director
- Mishal Shailesh Patel - Director
- Smita Kiran Davda - Director
- Sachin Bhandari - Director
The latest financial statements of Trident Lifeline on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Trident Lifeline is 24AAECT8906D1ZG, registered in Gujarat.
The CIN (Corporate Identification Number) of Trident Lifeline is L51909GJ2014PLC078227. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Trident Lifeline is a listed company as per MCA records. Its shares are listed on BSE (code: 543616).
Trident Lifeline has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the high courts.
Trident Lifeline was incorporated on 09 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Trident Lifeline has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022.
Sachin Bhandari was appointed as Director on 13 Jun 2026. Smita Kiran Davda was appointed as Director on 13 Jun 2026. Maniya Hardik Desai ceased to be Director on 22 Nov 2025. Trident Lifeline has 17 board changes on record in total.

